Boehringer Ingelheim U.S. Animal Health has announced that its poultry vaccine site in Gainesville, Georgia, has received carbon neutral certification. This is the first of its US sites to earn this designation. The site, which produces nearly 60 billion poultry vaccines every year, is Boehringer Ingelheim’s first major manufacturing facility site in the US and its third site globally to become carbon neutral. To reach carbon neutrality status, the site installed solar panels over the parking area, replaced fluorescent lightbulbs with LED bulbs, installed dimmer switches and occupancy sensors for lighting, purchased an electric vehicle for use around the site, installed smart meters to measure electrical consumption, and replaced insulation on equipment to reduce heat and energy loss. In addition, the company purchased environmental project carbon credits from Climate Seed. Employees at the site chose to invest in the Noles South Avoided Conversion Forest Project in North Carolina and a reforestation project in Kasigau Corridor in Kenya.